Skip to content

Comparing the efficacy of Albuterol Nebulizer and Albuterol plus Budesonide Nebulizer in treatment of Respiratory Distress Syndrome

Comparing the efficacy of Albuterol Nebulizer and Albuterol plus Budesonide Nebulizer in treatment of Respiratory Distress Syndrome

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016111617413N22
Enrollment
60
Registered
2016-11-26
Start date
2015-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory distress syndrome of newborn. Respiratory distress syndrome of newborn

Interventions

Intervention 1: The second group will undergo treatment with inhaler Albuterol plus Budesonide through jet nebulizer (400 mcg every 12 hours) for 3 to 5 days. Intervention 2: First group will undergo
Treatment - Drugs
The second group will undergo treatment with inhaler Albuterol plus Budesonide through jet nebulizer (400 mcg every 12 hours) for 3 to 5 days.
First group will undergo treatment with Albuterol Nebulizer 0.5 mg/kg every 8 hours for 3 to 5 days

Sponsors

Vice chancellor for research, Pharmaceutical Sciences Branch, Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 1 Months

Inclusion criteria

Inclusion criteria: Inclusion criteria: birth weight between 1000-2500 gr; gestational age of less than 36 weeks; mechanical ventilation for at least two days; oxygen saturation of more than 30% after extubation; pH55; PaO2<50. Exclusion criteria: hemorrhagic lesions; congenital anomalies; chromosomal anomalies; early sepsis; death before 72 hours of age.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
PH. Timepoint: before and after intervention. Method of measurement: Arterial Blood Gas Assessment.;Respiratory rate. Timepoint: before and after intervention. Method of measurement: one minute counting by nurse.;Blood Pressure. Timepoint: before and after intervention. Method of measurement: Monitoring System.;Oxygen Saturation. Timepoint: before and after intervention. Method of measurement: Pulse Oxymetry.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Hossein Khosravi

Student Research Committee, Baqiyatallah University of Medical Sciences, Tehran, Iran

dr.mhkhosravi@gmail.com+98 21 8862 0826

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026